sonolisib (PX 866) - Seattle Genetics
Wedbush Securities Life Sciences Management Access Conference (Oncothyreon) - Aug 16, 2011 - PX-866 / Oncothyreon; Anticipated P2 initial data in H2 '11 & final data in H1 '12 
Anticipated P2 data None • Oncology
http://www.larvolonline.com/tlg/ccdb/OncothyreonWedbushSecuritiesLifeSciencesManagementAccessConferenceAug16th2011.pdf
 
Aug 16, 2011
 
 
ea0cffa8-4e1e-4023-8706-20c548f4b39c.jpg

1daa4b06-fd58-4ac7-9b38-02092e61e547.jpg